Ethanol: Clinical Trials

55 trials of Ethanol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

32 completed, 5 recruiting, 5 terminated, 5 unknown. 55 Phase 3, 12 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 355Completed 32, Recruiting 5, Terminated 5, Unknown 5, Active not recruiting 4, Not yet recruiting 3, Suspended 1
Phase 212Completed 4, Recruiting 4, Active not recruiting 3, Unknown 1

Follow Ethanol: new trials by email Literature Review of Ethanol trials Research Report on Ethanol

Trials (filtered) newest first · largest first

All 55 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Periodontal Disease and Small Vulnerable Newborns in Rural Nepal: A Community-based Trial
A package of oral health interventions, including a daily antiseptic oral rinse (alcohol-free cetylpyridinium chloride (0.075%)) - Preterm Birth, Low Birth Weight
Phase 3Not yet recruitingJohns Hopkins Bloomberg School of Public Health22802026-12-312026-10-30
Effects of Ketones on Brain Energetics and Alcohol Consumption in Alcohol Use Disorder
Kenetik, magnetic resonance imaging scan, Alcohol bar lab - Alcohol Use Disorder, Ketosis
Phase 2 / Phase 3RecruitingUniversity of Pennsylvania602026-12-012026-10-21
Effectiveness Trial of an mHealth Intervention to Help Parents Prevent Early Onset Alcohol Use
BIPAS Alcohol - Alcohol Misuse, Alcohol Prevention
Phase 3Not yet recruitingRTI International40002026-10-152026-10-05
Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR)
Dehydrated Alcohol Injection, USP, Sham procedure - Hypertension, Hypertension,Essential
Phase 3Not yet recruitingAblative Solutions, Inc.2022026-10-012026-08-20
Effects of Ketone Supplement and Alcohol on Brain Metabolism
Kenetik, Alcohol beverage - Ketosis, Alcohol Drinking
Phase 2 / Phase 3Active not recruitingUniversity of Pennsylvania602025-05-132026-10-14
Efficacy of a Smartphone-Based JITAI to Reduce Drinking Among Adults Experiencing Homelessness
Smart-T Alcohol, Usual Care - Alcohol Misuse, Homeless
Phase 2 / Phase 3RecruitingUniversity of Oklahoma6002025-03-052026-05-01
Effect of Nutritional Ketosis on Alcohol Metabolism
Ketone Supplement, Control Diet, Ketogenic diet - Ketoses, Metabolic, Ketogenic Dieting
Phase 2 / Phase 3Active not recruitingUniversity of Pennsylvania232024-02-292026-04-07
The Effects of Sex Hormones and Alcohol on Sleep
Ethanol, Saline - Alcohol Use Disorder
Phase 3SuspendedOhio State University1302024-01-082026-09-28
Acute Effects of Ketone Supplement on Responses to Alcohol Challenge in Healthy Volunteers
Ketone Supplement, Alcohol Beverage - Alcohol Drinking
Phase 2 / Phase 3Active not recruitingUniversity of Pennsylvania102022-10-202026-08-06
Effect of Mouthwash in Reducing the Symptoms Associated With Flu and Cold Viruses
cetylpyridinium chloride (0.075%) and zinc alcohol free mouthwash - Healthy
Phase 3CompletedColgate Palmolive1502022-06-052026-10-07
Inhaled Isopropyl Alcohol for Treatment of Nausea
Inhaled Isopropyl Alcohol, Oral Ondansetron, Inhaled Placebo - Vomiting, Nausea
Phase 2 / Phase 3RecruitingState University of New York at Buffalo842022-04-202026-09-24
Efficacy and Safety of Ethanol Inhalation on COVID-19 Treatment (a Clinical Trial Study)
Ethanol, Water Distilled - Clinical Infection, Outcome
Phase 3CompletedAli Amoushahi1502021-09-022022-04-25
Perioperative Patient Skin Antiseptic Preparation Evaluation
70% v/v Isopropyl Alcohol Surgical Solution, 2%w/v Chlorhexidine Gluconate / 70% v/v Isopropyl Alcohol - Surgical Site Infection
Phase 3CompletedZurex Pharma, Inc.512021-06-212024-03-20
Ketone Ester Intervention in Alcohol Use Disorder
Ketone Ester "(R)-3-hydroxybutyl (R)-3-hydroxybutyrate", Isocaloric dextrose placebo, Alcohol drinks - Alcohol Drinking, Alcohol Use Disorder
Phase 2 / Phase 3RecruitingUniversity of Pennsylvania202021-04-052026-02-09
New Treatment for COVID-19 Using Ethanol Vapor Inhalation .
Ethanol with Asprin - Covid-19, Drug Effect
Phase 3UnknownMansoura University802020-12-012020-10-28
Topical Cetirizine in Androgenetic Alopecia in Females
Topical cetirizine, Placebo, Topical minoxidil - Androgenetic Alopecia
Phase 2 / Phase 3CompletedCairo University662020-07-252023-02-08
The Effect of Lidocaine and Benzocaine on Pain and Injection Satisfaction in Peripheral Intravenous Catheter Application
Lidocaine Spray, Benzokain Sprey, Alcohol - Peripheral Intravenous Catheterization Application
Phase 3CompletedTC Erciyes University1202020-03-042021-04-26
TARGET BP I Clinical Trial
Dehydrated alcohol, Peregrine System Kit (Sham Procedure) - Hypertension
Phase 3Active not recruitingAblative Solutions, Inc.3002019-07-222023-10-03
CHARM II: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts
Ethanol, Normal saline, Paclitaxel + Gemcitabine admixture - Pancreatic Cyst, EUS-FNA
Phase 3TerminatedMilton S. Hershey Medical Center752019-04-122026-03-30
In-vivo Efficacy of Patient Preoperative Prep, ZuraPrep (ZP)
ZuraPrep Clear Solution, ChloraPrep, ZuraPrep Vehicle - Surgical Skin Preparation
Phase 3CompletedZurex Pharma, Inc.1562019-01-252023-02-08

Showing 20 of 55. Sign in to see all of them.

Conditions studied

Alcohol Drinking (6)  ·  Hypertension (5)  ·  Alcoholism (4)  ·  Heart Diseases (3)  ·  Infections (3)  ·  Ketosis (3)  ·  Surgical Wound Infection (3)  ·  COVID-19 (2)  ·  Cardiovascular Diseases (2)  ·  Communicable Diseases (2)  ·  Sepsis (2)  ·  Vascular Diseases (2)  ·  Acute Kidney Injury (1)  ·  Alcohol-Related Disorders (1)  ·  Alcoholic Intoxication (1)

Sponsors

University of Pennsylvania (5)  ·  Zurex Pharma, Inc. (4)  ·  Ablative Solutions, Inc. (2)  ·  National Heart, Lung, and Blood Institute (NHLBI) (2)  ·  Solventum US LLC (2)  ·  University Hospital, Clermont-Ferrand (2)  ·  3M (1)  ·  ASST Fatebenefratelli Sacco (1)  ·  Akorn, Inc. (1)  ·  Ali Amoushahi (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Baylor College of Medicine (1)  ·  Baystate Medical Center (1)  ·  Ben-Gurion University of the Negev (1)  ·  C. R. Bard (1)

Countries

United States (32)  ·  France (4)  ·  Brazil (3)  ·  Mexico (2)  ·  Australia (1)  ·  Canada (1)  ·  Egypt (1)  ·  Iran (1)  ·  Israel (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Turkey (Türkiye) (1)

Top investigators

Corinde Wiers, Ph.D. (3)  ·  David Kandzari, MD (2)  ·  Michael Weber, MD (2)  ·  Alana Koehler, MD (1)  ·  Alejandro E. Macias, M. D. (1)  ·  Amanda Conti, MD (1)  ·  Anna Taddio, PhD (1)  ·  Asokumar Buvanendran, MD (1)  ·  Atul Pathak, MD (1)  ·  Atul Pathak, Prof. (1)  ·  Bart JA Rijnders, MD, PhD (1)  ·  Bellisa C Lopes, Master (1)  ·  Bertrand Souweine, Pr (1)  ·  Christine A McKiernan, MD (1)  ·  Corinde E Wiers, Ph.D. (1)

Results publications

PMID 32131912, PMID 12660125, PMID 16585662, PMID 19339405, PMID 20054046, PMID 20497980, PMID 20520776, PMID 22388536, PMID 23218847, PMID 23490572, PMID 24263324, PMID 25667135, PMID 25668557, PMID 26124071, PMID 26232779, PMID 26458258, PMID 27692023, PMID 29884572, PMID 31039759, PMID 31435005, PMID 32335895, PMID 32958438, PMID 33107945, PMID 33345865, PMID 34039478, PMID 35363884, PMID 35799302, PMID 36447221, PMID 36571611, PMID 37142273, PMID 37311720, PMID 38587557, PMID 40009628, PMID 41106729

NIH funding

R21AA031088 (2), R00AA026892 (1), R01AA015439 (1), R01AA030308 (1), R01AA031280 (1), R01AA031570 (1), R01AA031980 (1), R01CA222648 (1), R01DC012545 (1), R01HD119055 (1), R01HL021823 (1), R01HL024999 (1), R01HL115003 (1), U01HL060574 (1)